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Abstract
Background: Gallstones represent a prevalent and costly health problem. The changing epidemiology and the emerging
non-surgical interventions for gallstone disease necessitate the definition of target populations for future therapies. This
study aimed to define patterns of gallstone composition and identify demographic predictors of gallstone composition in
a large sample of symptomatic gallstones from Northern Germany.
Methods: One thousand and seventy-four post-cholecystectomy gallstone specimens were obtained. Demographic and
clinical information was provided by questionnaire (N = 1025 independent individuals with complete information). Two
samples from each gallstone were analyzed using Fourier transformed infrared spectrometry.
Results: The most prevalent substance was cholesterol, which was detected in 95.0% of gallstone specimens. Bilirubin
and bilirubinate were present in 30.0% and calcium was detected in 10.0% of the spectra. Ninety-two percent of
measurements from the same stone yielded the same "main" substances, indicating a homogenous stone composition in
most cases. Female sex and higher body mass index (BMI) were associated with the presence of cholesterol as a main
substance in the gallstones (p < 0.001).
Conclusion: The changing epidemiology of gallstone disease is reflected by a marked shift in stone composition: Only
two percent of stones in this study were pigment stones as compared to 91% percent of stones containing cholesterol
as a main substance. Obese individuals from Germany with a BMI > 30 kg/m2 have in 95% cholesterol-dominant gallstones
and represent a potential target population for non-surgical interventions for the prevention or treatment of cholesterol
stones.
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Background
Gallstones represent a serious burden for Western health-
care systems: 10–20% of Europeans and Americans carry
gallbladder stones [1,2]. The prevalence of gallstone dis-
ease is rising, possibly as a result of longer life expectancy
and altered nutritional habits. Many gallstones are silent,
but symptoms and complications ensue in around 25–
50% of cases, necessitating surgical removal of the gall-
bladder, usually by laparoscopic cholecystectomy [2,3].
Each year, more than 170,000 cholecystectomies are per-
formed in Germany [4]. Cholelithiasis incurs annual
medical expenses in excess of $6 billion in the US and is
currently the second most expensive digestive disease,
exceeded only by reflux disease [5]. The clinical manage-
ment of gallstone disease is almost exclusively based on
cholecystectomy and endoscopic or medical treatment of
complications. Cholecystectomy, although an established
procedure, still carries a small but existent complication
rate, especially when performed in an acute setting. Mor-
tality rates following cholecystectomy range from less
than 0.1% in clinical studies to 0.7% (as documented for
all cholecystectomies performed in Germany in 2004) [4].
In the US, about 3,000 deaths (0.12% of all deaths) per
year are attributed to complications of cholelithiasis and
gallbladder disease [6].
An improved etiological and pathophysiological under-
standing of gallstone disease may lead to novel, non-sur-
gical, options for prevention and therapy. Clinically, high
risk groups with small gallstones have recently been
defined [7]. Significant progress has been made both in
the genetics of gallstone formation [1,8] and in the molec-
ular biology of bile excretion [9-11]. Consequently, this
mechanistic knowledge may be lead to novel non-surgical
therapeutic or preventive strategies, as for instance shown
by the prevention of cholesterol gallstone formation in a
mouse model by FXR agonists [12] or the cholesterol
absorption inhibitor ezetimibe [13]. Gallstones, however,
are heteroneous both in terms of their composition and
their pathogenesis. The application of novel preventive or
therapeutic approaches will likely be limited to certain
classes of gallstones as defined by their composition and
etiology. Therefore, in order to select the correct patient
groups for such interventions, there is a need to idenitify
clinical predictors of stone composition.
Gallstone disease is a disorder with a changing prevalence,
reflecting the increasing life expectancy and changes in life
style in "westernized" societies [1]. In particular, the
increase of life style related risk factors was assumed to
result primarily in an increase of cholesterol gallstones
[14]. Gallstone composition, however, has not attracted
adequate attention in current population-based studies
leaving uncertainty regarding the confirmation of this
assumption. The impact of life style and ethnicity is
underscored by the profoundly different gallstone com-
positions in recent studies from sub-Saharan Africa [15]
and China [16,17].
Classical chemical analysis of gallstone samples is a very
laborious methodology. Fourier Transform Infrared
(FTIR) spectroscopy has been established as a means of
gallstone analysis by Japanese [18] and US investigators
[19]. The quantitative reliability has been confirmed in
systematic admixtures studies [19]. Thus, the utilization
of FTIR makes the analysis of larger series of gallstones
samples possible. We thus used FTIR, in order to define
target populations for future therapeutic and preventive
therapies and to investigate the possibly changing gall-
stone composition on a background of the rising preva-
lence. We obtained gallstone specimens from 1074
cholecystectomies from Northern Germany. We generated
descriptive measures of stone composition in this popula-
tion and investigated potential predictors of stone compo-
sition.
Methods
Patients and phenotypes
The 2001–2004 cholecystectomy statistics of Northern
Schleswig-Holstein were extracted from the German
National Quality Control data ("Qualitätssicherungs-
daten Cholezystektomie"). Ten hospitals were found to
have performed 93% of cholecystectomies in the region.
All patients who had undergone cholecystectomy for gall-
stone disease during the study period, and who at or
under the age of 65 years at the time of diagnosis, were
contacted via the respective treatment unit by mail and
offered participation in the study. One written reminder
was sent to non-responders. Individuals who agreed to
participate were interviewed by mail questionnaire. In
most departments, it is customary to hand the removed
gallstones to the patient. Participants were thus provided
with dedicated containers and asked to either send or
hand in their gallstones along with the questionnaire.
Recruitment was performed through "popgen", a compre-
hensive regional biobank project in Northern Schleswig-
Holstein [20], and utilised their technical, ethical and data
protection protocols. All study protocols were approved
by the institutional ethics committee ("Ethikkommission
des Universitätsklinikums Schleswig-Holstein, Kiel) and
by the public data protection agency. Written informed
consent was obtained from all study participants. Addi-
tional patient samples were (N = 204) recruited at the
Krankenhaus Lüneburg, a single centre outside Northern
Schleswig-Holstein, located in Northern Germany
approximately 200 kilometers from the popgen area.
Recruitment was performed following the procedures
described above.BMC Gastroenterology 2006, 6:36 http://www.biomedcentral.com/1471-230X/6/36
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In total, 9992 patients with operation records fulfilling
the recruitment criteria were identified and contacted by
mail. Out of these, 1539 patients could not be contacted,
because they had either changed address or had died since
the operation. Out of the remaining 8453 patients, 3174
patients participated in the overall study, i.e. provided
questionnaires and a venous blood sample. Out of these,
1074 patients were able to provide a gallstone. Part of this
are 87 consecutive patients, who were directly recruited in
the surgical department of the Kiel university during
2005. Therefore, compared to the total operated popula-
tion under or at the age of 65, 10.3% provided a gallstone
sample and complete clinical information (N = 1025).
This corresponds to 32.3% of the participating patients.
From all patients, information on the age at the time of
operation, sex, height and weight, parity and a family his-
tory in the first-degree relatives was obtained by question-
naire. Eighty-nine percent of patients were ethnic
Germans as defined by the birthplace of both parents.
Analysis of gallstone composition
Dry gallstone specimens were fragmented using a scalpel.
The weight of the gallstone was measured and two sam-
ples were obtained from each gallstone: The sites of sam-
pling of an individual stone were chosen to be as different
in macroscopic appearance as possible. For example, the
pigmented core and the yellow shell of a stone would
have been sampled if present. If multiple stones were
available for one patient, the largest stone was investi-
gated. The samples were ground separately with a pestle
and mortar to a homogenous powder. One to two milli-
grams of the resulting product were mixed with 300 mg
milligrams of potassium bromide (L.O.T.-Oriel, Darm-
stadt, Germany) and pressed with eight to nine tons (cor-
responding to 0.7 to 1 GPa) to generate a KBr disk with 13
mm diameter. These slices were measured using Fourier
Transform Infrared (FTIR) spectrometry on a FTS 155 FT-
IR spectrometer (Biorad, Hercules, Ca, USA) in a range of
400 to 4000 cm-1 at 4 cm-1 resolution. Control spectra
from the manufactures library were used and additional
spectra were obtained for analysis grade cholesterol,
bilirubin and synthesized samples of calcium and magne-
sium bilirubinate. Stone composition was determined on
the basis of the FTIR-spectra after analysis by the Biorad
Win-IR software (version 2.04).
To facilitate further analysis, the composition of the gall-
stones was classified into "main", "intermediate" and
"trace" components: Substances were assigned as "main"
components if they constituted more than 30% of the
gallstone (weight/weight). Components were classified as
"trace" components if the respective substance constituted
less then 10 percent (weight/weight) of the gallstone.
Components in the range of 10 to 30% were classified as
"intermediate". All bilirubinate salts were summarized as
"bilirubin", i.e. the different bilirubin salts were not differ-
entiated. A justification of this classification scheme is
given in the discussion.
Statistical analysis
Data was analyzed using the open source implementation
of the S statistical language in the R software package and
SPSS version 11. Contingency tables were analyzed
through chisquared statistics or Fisher's exact test, as
appropriate. Normality of distributions was assessed
using a one sample Kolmogorov-Smirnov test. Nonpara-
metric comparisons of non-normally distributed variables
were performed using the Wilcoxon test.
Results
Principal types of gallstones
A total of 1074 gallstone samples were available for anal-
ysis. The chemical substances detected in each gallstone
were classified as "main", "intermediate" or "trace" com-
ponents as described in the Methods section. The justifi-
cation for using this conservative classification rather than
estimated percentages is given in the discussion. Table 1
provides a descriptive overview of the detection of the
substances in the respective semiquantitative categories.
Numbers in each of the columns do not add up to 100%
because of the categorical classification schema. For
instance, up to three "main" substances were detected in
some gallstones (N = 5 with three "main" substances). If
a particular substance was detected in a higher quantita-
tive category, it was not listed in either of the other catego-
ries. Thus, the values in Table 1 can be for instance
interpreted as: "how often was substance X detected as a
trace substance in the stone samples?". The most preva-
lent substance was cholesterol, which was detected in
95.0% of gallstone specimens. Bilirubin was present in
30.0% and calcium was detected in 10.0% of the spectra.
Rare components of gallstones included palmitate/stear-
ate, polysaccharides and struvite, the being detected in
one gallstone.
Based on the apparent diversity in the stone composition,
two questions were asked: i) Are the substances given in
Table 1 freely combined or do the stone samples fall into
distinct categories?; and ii) to what extent are the two sam-
ples taken from the gallstones correlated – i. e. are stones
homogenous or heterogeneous in composition? To
answer the first question, the main and intermediate sub-
stances of the 2148 measurements were analyzed in a
cross-table (Table 2). Indeed, the components are not
freely combined, but the diversity of components reduces
to few composition types (p < 0.001). The most common
category is the dominant cholesterol stone (N = 1847) in
86% of analysed specimens. These stones would contain
70% or more cholesterol as no other "main" substanceBMC Gastroenterology 2006, 6:36 http://www.biomedcentral.com/1471-230X/6/36
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was detected. The next most common type of local com-
position is the combined cholesterol (as main substance)
and bilirubin (as intermediate) setting (4.1%). Dominant
calcium (1.0%) and dominant bilirubin (2.1%) composi-
tions are both already quite uncommon. All other types of
combinations of chemical substances were rare observa-
tions, with each less than 1% prevalence in the investi-
gated specimens. Based on the data in Table 2,
measurements were then classified. Class "C" denotes
dominant cholesterol compositions (cholesterol as a
main substance and no intermediate substances). The
other categories were cholesterol – bilirubin (CB),
bilirubin (B), calcium (CA) and other (O). The "O" cate-
gory totally accounted for 7.4% of spectra.
Using this categorization, the second question was tack-
led. The correlation of the two spectra obtained from each
gallstone was investigated in a cross-table (Table 3). This
table is principally populated along the diagonal – indi-
cating homogenous stone composition in most cases.
Specifically, in 82.5% of stones, both spectra yielded a
cholesterol composition. Interestingly, 0.2% of stones
yielded a pure "B" and "C" classification and 5.2% of
stones a "C" and "CB" classification. These stones corre-
spond to the previously described pigmented centers or
cholesterol stones with pigment layers [21]. Based on
Table 3, a patient-oriented classification of stone compo-
sition was generated as indicated in this table into the "C",
"CB", "B" and "O" categories. The composition of the gall-
stones from the 87 directly recruited consecutive patients
from the Kiel surgical department did not differ signifi-
cantly from the overall population (p > 0.2).
Correlation of patient and stone characteristics
For an exploratory analysis, the median and interquartile
ranges of the patient and stone characteristics were tabu-
lated by stone classification (Table 4). For this analysis,
stones from relatives and patients with incomplete demo-
graphic information were excluded yielding N = 1025
patients with a classified gallstone. None of the quantita-
tive measures followed a normal distribution (Komolgo-
rov-Smirnov-tests for goodness of fit p < 0.05). Thus
medians and interquartile ranges are used in the table and
non-parametric statistics were used for group compari-
sons. Interestingly, the "C" and "CB" classes of are very
similar in their characteristics (p > 0.05). The sex distribu-
tion between these two categories was, however, different
with 23% versus 38% males in the respective categories
(χ2 = 9.1, df = 1, p = 0.002). The stones that contained
more bilirubin than cholesterol (N = 12) but both as main
component (i.e. > 30% cholesterol), which were classified
as "CB" accounted for this difference. Overall, the most
striking differences were observed between the pigment
stones (B) on one hand and predominant cholesterol
stones (C and CB) on the other hand. The following
results refer to the comparison of these two groups: Pig-
ment stones are more prevalent in males (58%) than in
females (χ2 = 12.6, df = 1, p = 0.0008), and stones are
smaller with a median weight of 0.6 grams (Z = -3.7, p <
0.001). The age at operation was marginally significant
(Z=-2.0, p = 0.045), between the groups possibly due to
the lack of paediatric patients in the present sample. The
parity and differences in reported family history are not
statistically significant (p > 0.05). To further investigate
the difference in BMI between the pigment and choles-
terol stones, the prevalence of the combined C and CB
stones for different categories of BMIs are presented in
Table 5. Patients with lower BMIs have a lower prevalence
of cholesterol stones (χ2 = 17.0, df = 3, p = 0.0007). In the
subgroup analysis, this was significant in females (χ2 =
16.5, df = 3, p = 0.0009), and males (Fishers exact test
point p-value = 0.0003). The "other" stone category shares
Table 1: General descriptive overview of the composition of the gallstone samples:
Substance Main
(> 30%)
Intermediate
(10–30%)
Trace
(< 10%)
Qualitative presence
Cholesterol 93.3% 0.8% 0.9% 95.0%
Bilirubin 5.5% 4.7% 19.8% 30.0%
Calcium (any mineral) 10.0%
Ca5(PO4)3(F,Cl,OH) – Apatite 1.2% 0.4% 1.5% 3.1%
CaCO3 – Aragonite 1.3% 0.1% 0.1% 1.5%
CaCO3 – Calcite 1.0% 0.4% 0.3% 1.7%
CaCO3 – mineral not defined 1.3% 0.7% 1.7% 3.7%
Magnesium
Struvite (NH4)MgPO4·6H2O Not observed 0.1% Not observed 0.1%
Palmitate/Stearate 0.1% 0.3% 0.2% 0.7%
Polysaccharide 0.1% 0.2% 0.3% 0.6%
The frequency of detection of either of the substances in the 2148 FTIR spectra obtained from the 1074 gallstones is given in the left column for the 
quantitative classifications of "Main", "Intermediate" and "Trace" components. The term "Qualitative presence" refers to the detection of the 
respective substance in any of the categories. Note, that numbers will not sum to 100% due to presence of multiple stone components. All 
bilirubinate salts were summarized as "bilirubin", i.e. the different bilirubin salts were not differentiated.B
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Table 2: Principal stone types:
Intermediate substances
Main substances none Apatite Aragonite Bilirubin Bilirubin 
Apatite
Chol. Chol. 
Calcite
Chol. 
Palmitate
Ca Ca Apatite Ca Bilirubin Calcite Calcite 
Bilirubin
Palmitate Struvite Polysaccharide
Cholesterol 0.860 0.001 0.041 0.001 0.006 < 0.001 0.002 0.911
Cholesterol Bilirubin 0.013 < 0.001 < 0.001 0.014
Cholesterol Bilirubin, Apatite 0.003 0.003
Cholesterol Calcium 0.004 0.001 0.005
Bilirubin 0.021 0.001 < 0.001 0.002 0.001 < 0.001 0.001 0.027
Bilirubin Apatite 0.005 0.001 < 0.001 0.006
Bilirubin Aragonite 0.003 0.003
Bilirubin Calcium 0.001 0.001
Apatite < 0.001 < 0.001 0.001
Apatite Colesterol < 0.001 < 0.001
Apatite Calcium < 0.001 < 0.001
Aragonite 0.006 0.003 0.009
Aragonite Colesterol < 0.001 < 0.001
Calcium 0.002 0.002 0.001 0.001 0.006
Calcite 0.007 0.001 0.008
Calcite Apatite 0.001 0.001
Calcite Cholesterol 0.001 0.001
Stearate 0.001 0.001
Polysaccharide 0.001 0.001
The main and intermediate substances from all 2148 FTIR measurements are displayed in this cross-table. It is evident, that the various stone components are not mixed at random but rather fall into few, 
specific categories. Cells with "pure" stones and a frequency above 1% are marked in bold print. The combination of cholesterol and bilirubin (two cells) is marked in underlined italics. Values of "< 0.001" 
correspond to single observations. Abbreviations in the Table heading: Chol. Corresponds to Cholesterol and Ca corresponds to Calcium.BMC Gastroenterology 2006, 6:36 http://www.biomedcentral.com/1471-230X/6/36
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many similarities in patient characteristics with the cho-
lesterol stones (Table 4). Due to the small number and
heterogeneous composition of this group of stones, epide-
miological predictors were not explored in further detail.
As an illustration of the different stone types, a photo-
graph of representatives of the respective groups is pro-
vided [see Additional file 1].
Discussion
Fourier Transform Infrared (FTIR) spectroscopy has been
established as a means to the rapid assessment of the com-
position of gallstones [18,19]. Only this methodology
enabled the analysis of the over 1000 stone samples and
was thus used to investigate this large sample of gall-
stones. We have chosen to present the results of the FTIR
in a semi-quantitative classification rather than exact
numbers of the proportion of the respective stone compo-
nents, because the direct quantification of components
using FTIR is limited by some interfering factors: Namely,
interaction of the components with the KBr, differences in
hydration, ion exchange reactions, the degree of disper-
sion between KBr and gallstone components, the Chris-
tiansen-effect and/or possible chemical reactions of
components can influence the relative height and appear-
ance of the spectrum peaks [22-24]. Thus, in order to
obtain robust (and conservative) estimates of gallstone
composition, the substances were classified into "main",
"intermediate" and "trace" components (as described in
the Methods section) rather than being expressed in
explicit percentages.
The fine structure [21,25], bacterial colonization [26] and
mechanistics of gallstone generation [27-30] have been
studied in detail in previous experiments. We think, that
this study still makes a substantial contribution in that it
has focussed more on a general epidemiological survey of
gallstone composition mainly to determine the principal
components of the current gallstones in order to help
identify patients for future innovative non-surgical inter-
ventions [12]: In the descriptive statistics of gallstone
composition, two main conclusions can be drawn: Firstly,
gallstones in the investigated population are quite
homogenous in terms of their main components: In only
eightytwo (7.6%, including sixty stones, that contained
bilirubin/cholesterol combinations) out of 1074 stones,
different main substances were identified in the two sam-
ples taken from each stone (Table 3). Most of this relates
to the inclusion of bilirubin in otherwise dominant cho-
lesterol stones, thus representing the pigment cores or
rings in cholesterol gallstones, which have been studied
previously in detail [21]. The other source of heterogene-
Table 4: Exploratory analysis of stone composition in 1025 unrelated index patients.
BCC B O
N 19 846 85 75
stone weight 0.6 (0.2–1.1) g 1.6 (0.7–3.4) g 2.0 (1.0–4.9) g 0.7 (0.2 – 1.5) g
%male 58% 23% 38% 28%
BMI 25.5 (23.1 – 29.1) 27.1 (24.7 – 30.4) 27.1 (25.0 – 29.1) 27.0 (23.7 – 29.0)
parity (females) 2 (2 – 2) 2 (1 – 3) 2 (1 – 2) 2 (2 – 2)
age of operation 60 (48 – 63) 53 (43–60) 56 (44–62) 55 (47 – 61)
family history 53% 46% 45% 36%
For quantitative measures (stone weight, BMI, parity, age of operation), the median and interquartile range are reported. Other measures are 
expressed as percentages. The family history refers to a positive family history of gallstones (either history of cholecystectomy or self-reported 
presence of gallstone based on previous sonography) in a first degree relative.
Table 3: Comparison of the two spectra obtained from the same stone:
Spectrum B
Spectrum A C B CB O
C0 . 8 2 5
B 0.002 0.019
CB 0.052 0.002 0.027
O 0.016 0.001 0.004 0.053
Two FTIR spectra were obtained from each gallstone from two sites chosen to be macroscopically as different as possible. The symmetrical fields 
on the upper right hand corner of the table were collapsed into the triangular shape for ease of interpretation. It is evident, that stones are quite 
homogenous with 92.4 percent of stones yielding the same classification in both measurements. Based on this table, gallstones were classified for 
the following patient-oriented analyses as "C" (cholesterol), "B" (bilirubin), "CB" (cholesterol – bilirubin: underlined italics in the table) and "O" 
(other – bold italics).BMC Gastroenterology 2006, 6:36 http://www.biomedcentral.com/1471-230X/6/36
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ity stems from calcium as an admixture to gallstones
[25,31]. The quantitatively major components of gall-
stones identified in this experiments are cholesterol,
bilirubin (pigment) [32] and calcium carbonate [31] with
93.3%, 5.5% and 4.8% relative frequencies of detection as
main substances (Table 2). These major components are
not randomly assembled in gallstones (p < 0.001), but the
composition falls into distinct classes of gallstones,
namely cholesterol, bilirubin (pigment) and calcium
stones. This classification has obviously been developed
before and is here confirmed on a more formal level.
Thus, for further analysis, stones were classified into four
classes (for exact definition see the Results section). Cal-
cium was detected only in 10% of gallstones, which has
implication for the sonographic and radiographic detec-
tion of these concrements.
Interestingly, the age of onset was not strongly correlated
to stone composition (p = 0.045), this is probably due to
the lack of coverage of the paediatric population in this
survey: The youngest patients in this study were 18 years
at diagnosis. Thus, the reported very different gallstone
composition of approximately 50% pigment stones and
35% calcium stones in children [33,34] was not observed
here.
As a main result of the search for epidemiological predic-
tors of stone composition, sex and BMI were identified:
Both associations were significant (p < 0.001). Interest-
ingly, in obese individuals (BMI≥30), approximately 95%
of gallstones consist predominantly of cholesterol for
both men and women. Thus, the increase in gallstone
prevalence and the association of overall gallstone risk
with higher BMI [2] are likely resulting primarily in an
increase of cholesterol gallstones.
The study has addressed a selected patient population and
is thus not population-representative: This applies to the
focus on younger patients who were operated at an age
under 65, the overall response rate as compared to the
total operated population of (10.3%) and to potential
bias introduced through storage of gallstone samples by
the patients. Here, the personality traits of the patients
(orderliness etc.) and the stability of stones may have
played a role. Stones that tend to disintegrate are more
likely to be of rarer composition types (polysaccharide,
certain calcium stones) and may have been thus underrep-
resented in this investigation. The overall pattern of stone
composition was similar in the 87 consecutive patients
directly recruited at the Kiel university hospital in 2005
thus indicating, that main findings may robust against
these potential selection bias factors.
Taken the limitations noted above into account, the study
shows the changing patterns of gallstone disease and con-
firms the need for the present investigation. In this exper-
iment cholesterol stones represent the by far dominating
type of gallstone. In contrast, studies from the 1960is and
1970ies have shown prevalences of pigment stones of 23
[19] to 30 percent [35]. In our study, pigment stones are
relatively infrequent with only two percent of stones in
the present sample of symptomatic gallstones. Previous
studies from Western countries have also shown a pre-
dominance of cholesterol stones with 100% of patients
under the age of 50 and 60% for older patients [36] in a
Dutch study and 58% of cholesterol stones in a U.S. study
using visual inspection of stones [19]. If the definition of
a cholesterol stone from van Erpecum et al. is adapted to
our data, 91.1% of stones contain 70% or more choles-
terol (row 1 of Table 2). Some 2.2% of stones contain
between 30 and 70% cholesterol and cannot be clearly by
put into the 50% categorisation (rows 2–3 of Table 2).
Although no correlation of age of operation and stone
composition was found, this might be due to the exclu-
sion of old patients with gallstones. Thus, the high pro-
portion of cholesterol gallstones in this investigation may
be due to this age selection and also related to the same
altered nutritional patterns that also lead to an increase in
gallstone prevalence in susceptible populations.
Conclusion
In summary, this study documents a dramatic change in
gallstone composition – in the high-prevalence region of
Northern Germany – with a overwhelming preponder-
ance of cholesterol-based gallstones. This is in contrast to
the gallstone composition in recent studies from sub-
Saharan Africa [15] and China [16,17]. Based on the find-
ings of this study, a potential homogenous target popula-
Table 5: Joint presence of the "C" and "CB" stone compositions in relation to sex and BMI.
Sex BMI
0–20 20–25 25–30 > 30
All 74% 89% 91% 95%
f e m a l e 7 2 %9 1 %9 2 %9 4 %
m a l e 8 3 %7 9 %8 8 %9 6 %
The frequency of this composite type of gallstone in the respective age and BMI categories is reported.BMC Gastroenterology 2006, 6:36 http://www.biomedcentral.com/1471-230X/6/36
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tion in Germany for non-surgical intervention [12,13] for
the prevention of cholesterol stones would be obese indi-
viduals with a BMI > 30, for which approximately 95% of
cholesterol gallstones were observed in both males and
females.
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